The global Hyperthyroidism Medications market was valued at US$ 466.1 million in 2023 and is projected to reach US$ 699.6 million by 2030, at a CAGR of 6.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.